Cholestyramine and Neoplasm malignant - a phase IV clinical study of FDA data

Summary:

Neoplasm malignant is reported as a side effect among people who take Cholestyramine (cholestyramine), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Prednisone, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Neoplasm malignant when taking Cholestyramine. It is created by eHealthMe based on reports of 9,676 people who have side effects when taking Cholestyramine from the FDA, and is updated regularly.

What is Cholestyramine?

Cholestyramine has active ingredients of cholestyramine. It is often used in diarrhea. eHealthMe is studying from 9,893 Cholestyramine users. Check the latest studies of Cholestyramine.

What is Neoplasm malignant?

Neoplasm malignant (cancer tumour) is found to be associated with 1,539 drugs and 1,261 conditions by eHealthMe. Check the latest studies of Neoplasm malignant.

On Aug, 12, 2026

9,676 people reported to have side effects when taking Cholestyramine.
Among them, 34 people (0.35%) have Neoplasm malignant.

Could Cholestyramine cause Neoplasm malignant?

Among these 34 people:

How long have people been on Cholestyramine when they have Neoplasm malignant? *

What is the gender of people who have Neoplasm malignant when taking Cholestyramine? *

female: 58.82 %
male: 41.18 %

What is the age of people who have Neoplasm malignant when taking Cholestyramine? *

What are other drugs people take besides Cholestyramine? *

What are other side effects people have besides Neoplasm malignant? *

Stress And Anxiety: 9 people, 26.47%
Renal Disorder (kidney disease): 8 people, 23.53%
Nausea (feeling of having an urge to vomit): 8 people, 23.53%
Weight Decreased: 8 people, 23.53%
Weakness: 7 people, 20.59%
Pain: 7 people, 20.59%
Dehydration (dryness resulting from the removal of water): 7 people, 20.59%
Feeling Abnormal: 6 people, 17.65%
Tremor (trembling or shaking movements in one or more parts of your body): 6 people, 17.65%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 6 people, 17.65%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 5 people, 14.71%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 4 people, 11.76%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 8.82%
Neuroendocrine Tumor: 3 people, 8.82%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 8.82%
Thyroid Diseases: 3 people, 8.82%
Post Procedural Complication: 3 people, 8.82%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 8.82%
Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 5.88%
Constipation: 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Cholestyramine and have Neoplasm malignant?

- Check whether Neoplasm malignant is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cholestyramine:

Cholestyramine (9,893 reports)

Browse all side effects of Cholestyramine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neoplasm malignant:

Neoplasm malignant (1,539 drugs)

Browse all the conditions that are associated with Neoplasm malignant:

Neoplasm malignant (1,261 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cholestyramine (the active ingredients of Cholestyramine) and Cholestyramine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.